Abstract
Primary vitreoretinal lymphoma (PVRL) is a rare malignancy that is speculated to arise extraocularly, and preferentially invade and flourish in the ocular and CNS microenvironments. The eye is involved in about 20% of primary central nervous system lymphomas, but the brain is eventually involved in about 80% of PVRL. Most are B-cell lymphomas with small numbers of T-cell lymphomas metastatic to the vitreous and retina. Metastatic systemic B-cell lymphoma usually involves choroid. Primary choroidal lymphoma is rare. Intraocular lymphoma can usually be distinguished from uveitis clinically, although there are overlaps, which may be pronounced in eyes with a large component of reactive inflammation related to tumor surveillance and control. There are controversies in diagnosis and treatment. Diagnosis through examination of ocular fluid is technically difficult and can utilize cytology, immunohistochemistry, flow cytometry, molecular detection of gene rearrangements, and cytokine profiling. Treatment of intraocular lymphoma without detectable CNS disease could consist of a full course of systemic chemotherapy with ocular adjunctive treatment, or ocular treatment alone depending on the preference of the clinical center. In ocular only cases where the vitreous has been debulked to improve vision and there is no sight-threatening involvement of the RPE, orbital irradiation or intravitreal chemotherapy stabilizes the intraocular process but does not seem to modify the CNS component, which can present symptomatically in an advanced state. This is a highly malignant disease with a poor prognosis. Close collaboration with a pathologist and oncologist, and good communication with patients is essential.
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Mochizuki M, Singh AD . Epidemiology and clinical features of intraocular lymphoma. Ocul Immunol Inflamm 2009; 17: 69–72.
Chan CC, Rubenstein JL, Coupland SE, Davis JL, Harbour JW, Johnston PB et al. Primary vitreoretinal lymphoma: a report from an international primary central nervous system lymphoma collaborative group symposium. Oncologist 2011; 16: 1589–1599.
Coupland SE, Damato B . Understanding intraocular lymphomas. Clin Experiment Ophthalmol 2008; 36: 564–578.
Coupland SE, Foss HD, Hidayat AA, Cockerham GC, Hummel M, Stein H . Extranodal marginal zone B cell lymphomas of the uvea: an analysis of 13 cases. J Pathol 2002; 197: 333–340.
Cao X, Shen D, Callanan DG, Mochizuki M, Chan CC . Diagnosis of systemic metastatic retinal lymphoma. Acta Ophthalmol 2011; 89: e149–e154.
Coupland SE, Heimann H, Bechrakis NE . Primary intraocular lymphoma: a review of the clinical, histopathological and molecular biological features. Graefes Arch Clin Exp Ophthalmol 2004; 242: 901–913.
Gonzales JA, Chan CC . Biopsy techniques and yields in diagnosing primary intraocular lymphoma. Int Ophthalmol 2007; 27: 241–250.
Davis JL, Solomon D, Nussenblatt RB, Palestine AG, Chan CC . Immunocytochemical staining of vitreous cells. Indicat Tech Result Ophthalmol 1992; 99: 250–256.
Davis JL, Miller DM, Ruiz P . Diagnostic testing of vitrectomy specimens. Am J Ophthalmol 2005; 140: 822–829.
Kimura K, Usui Y, Goto H, The Japanese Intraocular Lymphoma Study Group. Clinical features and diagnostic significance of the intraocular fluid of 217 patients with intraocular lymphoma. Jpn J Ophthalmol 2012; 56: 383–389.
Wang Y, Shen D, Wang VM, Sen HN, Chan CC . Molecular biomarkers for the diagnosis of primary vitreoretinal lymphoma. Int J Mol Sci 2011; 12: 5684–5697.
Cassoux N, Giron A, Bodaghi B, Tran TH, Baudet S, Davy F et al. IL-10 measurement in aqueous humor for screening patients with suspicion of primary intraocular lymphoma. Invest Ophthalmol Vis Sci 2007; 48: 3253–3259.
Berenbom A, Davila RM, Lin HS, Harbour JW . Treatment outcomes for primary intraocular lymphoma: implications for external beam radiotherapy. Eye 2007; 21: 1198–1201.
Stefanovic A, Davis J, Murray T, Markoe A, Lossos IS . Treatment of isolated primary intraocular lymphoma with high-dose methotrexate-based chemotherapy and binocular radiation therapy: a single-institution experience. Br J Haematol 2010; 151: 103–106.
Frenkel S, Hendler K, Siegal T, Shalom E, Pe’er J . Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience. Br J Ophthalmol 2008; 92: 383–388.
Itty S, Pulido JS . Rituximab for intraocular lymphoma. Retina 2009; 29: 129–132.
Sen HN, Chan CC, Byrnes G, Fariss RN, Nussenblatt RB, Buggage RR . Intravitreal methotrexate resistance in a patient with primary intraocular lymphoma. Ocul Immunol Inflamm 2008; 16: 29–33.
Hormigo A, Abrey L, Heinemann MH, DeAngelis LM . Ocular presentation of primary central nervous system lymphoma: diagnosis and treatment. Br J Haematol 2004; 126: 202–208.
Grimm SA, McCannel CA, Omuro AM, Ferreri AJ, Blay JY, Neuwelt EA et al. Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group report. Neurology 2008; 71: 1355–1360.
McCann KJ, Ashton-Key M, Smith K, Stevenson FK, Ottensmeier CH . Primary central nervous system lymphoma: tumor-related clones exist in the blood and bone marrow with evidence for separate development. Blood 2009; 113: 4677–4688.
Zamora DO, Rivere M, Choi D, Pan Y, Planck SR, Rosenbaum JR et al. Proteomic profiling of human retinal and choroidal endothelial cells reveals molecular heterogeneity related to tissue of origin. Mol Vis 2007; 13: 2058–2065.
Velez G, de Smet MD, Whitcup SM, Robinson M, Nussenblatt RB, Chan CC . Iris involvement in primary intraocular lymphoma: report of two cases and review of the literature. Surv Ophthalmol 2000; 44: 518–526.
Chan CC, Fischette M, Shen D, Mahesh SP, Nussenblatt RB, Hochman J . Murine model of primary intraocular lymphoma. Invest Ophthalmol Vis Sci 2005; 46: 415–419.
Sauer TC, Meyers SM, Shen D, Vegh S, Vygantas C, Chan CC . Primary intraocular (retinal) lymphoma following ocular toxoplasmosis. Retin Cases Brief Rep 2010; 4: 160–163.
Malumbres R, Davis J, Ruiz P, Lossos IS . Somatically mutated immunoglobulin IGHV@ genes without intraclonal heterogeneity indicate a postgerminal centre origin of primary intraocular diffuse large B-cell lymphomas. Br J Haematol 2007; 138: 749–755.
Cockerham GC, Hidayat AA, Bijwaard KE, Sheng ZM . Re-evaluation of ‘reactive lymphoid hyperplasia of the uvea’: an immunohistochemical and molecular analysis of 10 cases. Ophthalmology 2000; 107: 151–158.
Mineo JF, Scheffer A, Karkoutly C, Nouvel L, Kerdraon O, Trauet J et al. Using human CD20-transfected murine lymphomatous B cells to evaluate the efficacy of intravitreal and intracerebral rituximab injections in mice. Invest Ophthalmol Vis Sci 2008; 49: 4738–4745.
Chan CC, Shen D, Hackett JJ, Buggage RR, Tuaillon N . Expression of chemokine receptors, CXCR4 and CXCR5, and chemokines, BLC and SDF-1, in the eyes of patients with primary intraocular lymphoma. Ophthalmology 2003; 110: 421–426.
Galand C, Donnou S, Crozet L, Brunet S, Touitou V, Ouakrim H et al. Th17 cells are involved in the local control of tumor progression in primary intraocular lymphoma. PLoS One 2011; 6: e24622.
Kitzmann AS, Pulido JS, Mohney BG, Baratz KH, Grube T, Marler RJ et al. Intraocular use of rituximab. Eye (Lond) 2007; 21: 1524–1527.
Turaka K, Bryan JS, De Souza S, Gordon AJ, Kwong HM, Ziemianski MC et al. Vitreoretinal lymphoma: changing trends in diagnosis and local treatment modalities at a single institution. Clin Lymphoma Myeloma Leuk 2012; S2152-2650 (12): 00141–00143.
Kennerdell JS, Johnson BL, Wisotzkey HM . Vitreous cellular reaction. Association with reticulum cell sarcoma of brain. Arch Ophthalmol 1975; 93: 1341–1345.
Cummings TJ, Stenzel TT, Klintworth G, Jaffe GJ . Primary intraocular T-cell-rich large B-cell lymphoma. Arch Pathol Lab Med 2005; 129: 1050–1053.
Forsyth PA, DeAngelis LM . Biology and management of AIDS-associated primary CNS lymphomas. Hematol Oncol Clin North Am 1996; 10: 1125–1134.
Thomas JA, Crawford DH, Burke M . Clinico-pathologic implications of Epstein-Barr virus related B cell lymphoma in immunocompromised patients. J Clin Pathol 1995; 48: 287–290.
Usui Y, Wakabayashi Y, Okunuki Y, Kimura K, Tajima K, Matsuda R et al. Immune mediators in vitreous fluids from patients with vitreoretinal B-cell lymphoma. Invest Ophthalmol Vis Sci 2012; 53: 5395–5402.
Valentincic NV, de Groot-Mijnes JD, Kraut A, Korosec P, Hawlina M, Rothova A . Intraocular and serum cytokine profiles in patients with intermediate uveitis. Mol Vis 2011; 17: 2003–2010.
Fardeau C, Lee CP, Merle-Béral H, Cassoux N, Bodaghi B, Davi F et al. Retinal fluorescein, indocyanine green angiography, and optic coherence tomography in non-Hodgkin primary intraocular lymphoma. Am J Ophthalmol 2009; 147: 886–894.
Ishida T, Ohno-Matsui K, Kaneko Y, Tobita H, Shimada N, Takase H et al. Fundus autofluorescence patterns in eyes with primary intraocular lymphoma. Retina 2010; 30: 23–32.
Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 2005; 140: 509–516.
Sugita S, Takase H, Sugamoto Y, Arai A, Miura O, Mochizuki M . Diagnosis of intraocular lymphoma by polymerase chain reaction analysis and cytokine profiling of the vitreous fluid. Jpn J Ophthalmol 2009; 53: 209–214.
Lobo A, Lightman S . Vitreous aspiration needle tap in the diagnosis of intraocular inflammation. Ophthalmology 2003; 110: 595–599.
Yeh S, Weichel ED, Faia LJ, Albini TA, Wroblewski KK, Stetler-Stevenson M et al. 25-Gauge transconjunctival sutureless vitrectomy for the diagnosis of intraocular lymphoma. Br J Ophthalmol 2010; 94: 633–638.
Coupland SE, Perez-Canto A, Hummel M, Stein H, Heimann H . Assessment of HOPE fixation in vitrectomy specimens in patients with chronic bilateral uveitis (masquerade syndrome). Graefes Arch Clin Exp Ophthalmol 2005; 243: 847–852.
Davis JL, Ruiz P, Shah M, Mandelcorn E . Evaluation of the reactive t cell infiltrate in uveitis and intraocular lymphoma with flow cytometry of vitreous fluid. An AOS thesis. Trans Am Ophth Soc 2012 (in press).
Zaldivar RA, Martin DF, Holden JT, Grossniklaus HE . Primary intraocular lymphoma: clinical, cytologic, and flow cytometric analysis. Ophthalmology 2004; 111: 1762–1767.
Raparia K, Chang CC, Chévez-Barrios P . Intraocular lymphoma: diagnostic approach and immunophenotypic findings in vitrectomy specimens. Arch Pathol Lab Med 2009; 133: 1233–1237.
Kojima K, Maruyama K, Inaba T, Nagata K, Yasuhara T, Yoneda K et al. The CD4/CD8 Ratio in vitreous fluid is of high diagnostic value in sarcoidosis. Ophthalmology 2012; 119 (11): 2386–2392.
Lugli E, Roederer M, Cossarizza A . Data analysis in flow cytometry: the future just started. Cytometry A 2010; 77: 705–713.
Yeh S, Karne NK, Kerkar SP, Heller CK, Palmer DC, Johnson LA et al. Ocular and systemic autoimmunity after successful tumor-infiltrating lymphocyte immunotherapy for recurrent, metastatic melanoma. Ophthalmology 2009; 116: 981–989.
Bashir R, Chamberlain M, Ruby E, Hochberg FH . T-cell infiltration of primary CNS lymphoma. Neurology 1996; 46: 440–444.
Evans PA, Ch Pott, Groenen PJ, Salles G, Davi F, Berger F et al. Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia 2007; 21: 207–214.
Baehring JM, Androudi S, Longtine JJ, Betensky RA, Sklar J, Foster CS et al. Analysis of clonal immunoglobulin heavy chain rearrangements in ocular lymphoma. Cancer 2005; 104: 591–597.
Rajagopal R, Harbour JW . Diagnostic testing and treatment choices in primary vitreoretinal lymphoma. Retina 2011; 31: 435–440.
Velez G, Boldt HC, Whitcup SM, Nussenblatt RB, Robinson MR . Local methotrexate and dexamethasone phosphate for the treatment of recurrent primary intraocular lymphoma. Ophthalmic Surg Lasers 2002; 33: 329–333.
Helbig H, Cerny T, de Smet MD . [Intravitreal chemotherapy for intraocular lymphoma]. Ophthalmologe 2003; 100: 145–149.
Chan CC, Fisson S, Bodaghi B . The future of primary intraocular lymphoma (retinal lymphoma). Ocul Immunol Inflamm 2009; 17: 375–379.
Coupland SE, Hummel M, Müller HH, Stein H . Molecular analysis of immunoglobulin genes in primary intraocular lymphoma. Invest Ophthalmol Vis Sci 2005; 46: 3507–3514.
Wieduwilt MJ, Valles F, Issa S, Behler CM, Hwang J, McDermott M et al. Immunochemotherapy with intensive consolidation for primary CNS lymphoma: a pilot study and prognostic assessment by diffusion-weighted MRI. Clin Cancer Res 2012; 18: 1146–1155.
Acknowledgements
This research was supported by Len-Ari Foundation, Research to Prevent Blindness.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Presented 14 September 2012 at the Cambridge Ophthalmological Symposium: cancer and the eye.
Rights and permissions
About this article
Cite this article
Davis, J. Intraocular lymphoma: a clinical perspective. Eye 27, 153–162 (2013). https://doi.org/10.1038/eye.2012.250
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/eye.2012.250
Keywords
This article is cited by
-
Diagnosis and management of vitreoretinal lymphoma: present and future treatment perspectives
Japanese Journal of Ophthalmology (2023)
-
First observation of intraocular extranodal natural killer/T-cell lymphoma secondary to a retroperitoneal tumour: a case report and comparative review
BMC Ophthalmology (2022)
-
Epidemiology and survival outcomes of patients with primary intraocular lymphoma: a population-based analysis
BMC Ophthalmology (2022)
-
Clinical sign and symptom of primary vitreoretinal lymphoma short-time after retinal reattachment surgery: a case report
Journal of Ophthalmic Inflammation and Infection (2022)
